ScholarWorks@Gyeongsang National University

Browsing by Lee, JeeyunAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 17 of 17

SCIESCOPUS
A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer

Hwang, In Gyu; Ji, Yin Ho; Kang, Jung Hun; Lee, Hyo Rak; Lee, Hui-Young; Chi, Kyong-Choun; Park, Suk Won; Lee, Su Jin; Kim, Seung Tae; Lee, Jeeyun, et al.

ArticleIssue Date2017CitationJOURNAL OF GERIATRIC ONCOLOGY, v.8, no.3, pp 170 - 175PublisherELSEVIER SCIENCE BV
SCIESCOPUS
A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor-Induced Skin Toxicitiesopen access

Kim, Young Saing; Ji, Jun Ho; Oh, Sung Yong; Lee, Suee; Huh, Seok Jae; Lee, Ji Hyun; Song, Ki-Hoon; Son, Choon Hee; Roh, Mee Sook; Lee, Gyeong Won, et al.

ArticleIssue Date2020CitationONCOLOGIST, v.25, no.1, pp E186 - E193PublisherWILEY
SCIESCOPUSKCI
A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histologyopen access

Yi, Jun Ho; Kang, Jung Hun; Hwang, In Gyu; Ahn, Hee Kyung; Baek, Hyun Jin; Lee, Soon Il; Lim, Do Hyoung; Won, Young-Woong; Ji, Jun Ho; Kim, Hyo Song, et al.

ArticleIssue Date2016CitationCANCER RESEARCH AND TREATMENT, v.48, no.2, pp 553 - 560PublisherKOREAN CANCER ASSOCIATION
SCISCIESCOPUS
ARTIST 2: Interim results of a phase III trial involving adjuvant chemotherapy and/or chemoradiotherapy after D2-gastrectomy in stage II/III gastric cancer (GC).

Park, Se Hoon; Zang, Dae Young; Han, Boram; Ji, Jun Ho; Kim, Tae Gyu; Oh, Sung Yong; Hwang, In Gyu; Kim, Jung Hoon; Shin, Dongbok; Lim, Do Hoon, et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCISCIESCOPUS
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy

Kim, Tae Gyu; Park, Won; Kim, Hakyoung; Choi, Doo Ho; Park, Hee Chul; Kim, Seok-Hyung; Cho, Yong Beom; Yun, Seong Hyen; Kim, Hee Cheol; Lee, Woo Yong, et al.

ArticleIssue Date2019CitationTumori, v.105, no.5, pp 434 - 440PublisherII Pensiero Scientifico Editore srl
SCIESCOPUS
Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trialopen access

Kim, Seung Tae; Oh, Sung Yong; Lee, Jeeyun; Kang, Jung Hun; Lee, Hyun Woo; Lee, Myung Ah; Sohn, Byeong Seok; Hong, Ji Hyong; Park, Young Suk; Park, Joon Oh, et al.

ArticleIssue Date2019CitationJOURNAL OF CANCER, v.10, no.25, pp 6185 - 6190PublisherIVYSPRING INT PUBL
SCIESCOPUS
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study

Lee, Jeeyun; Park, Se Hoon; Chang, Heung-Moon; Kim, Jun Suk; Choi, Hye Jin; Lee, Myung Ah; Jang, Joung Soon; Jeung, Hei Cheul; Kang, Jung Hun; Lee, Hyun Woo, et al.

ArticleIssue Date2012CitationLANCET ONCOLOGY, v.13, no.2, pp 181 - 188PublisherELSEVIER SCIENCE INC
SCIESCOPUS
Meso-macroporous hydrogel for direct litre-scale isolation of extracellular vesicles

Kim, Junbeom; Kang, Minjin; Han, Geonhee; Hyung, Sujin; Kim, Mina; Jang, Minjeong; Lee, Han Kyul; Seo, Yunhee; Gil, Ki Cheol; Kim, Changheon, et al.

ArticleIssue Date2025CitationNature Nanotechnology, v.20, no.11, pp 1678 - 1687PublisherNature Publishing Group
SCIESCOPUS
Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07open access

Kim, Seung Tae; Kim, Sun Young; Lee, Jeeyun; Yun, Seong Hyeon; Kim, Hee Cheol; Lee, Woo Yong; Kim, Tae Won; Hong, Yong Sang; Lim, Seok-Byung; Baek, Ji Yeon, et al.

ArticleIssue Date2022CitationJournal of Clinical Oncology, v.40, no.33, pp 3868 - 3877PublisherAmerican Society of Clinical Oncology
SCIESCOPUS
Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-09)

Kim, Miso; Kim, Yu Jung; Suh, Koung Jin; Kim, Se Hyun; Kim, Jeong Eun; Jeong, Juhyeon; Hong, Jung Yong; Lee, Jeeyun; Lee, Su Jin; Oh, Sung Yong, et al.

ArticleIssue Date2025CitationCancer, v.131, no.1PublisherJohn Wiley & Sons Inc.
SCISCIESCOPUS
Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effects

Hwang, In Gyu; Kang, Jung Hun; Oh, Sung Yong; Lee, Suee; Kim, Sung-Hyun; Song, Ki-Hoon; Son, Choonhee; Park, Min Jae; Kang, Myung Hee; Kim, Hoon Gu, et al.

ArticleIssue Date2016CitationSUPPORTIVE CARE IN CANCER, v.24, no.1, pp 301 - 309PublisherSPRINGER
SCIESCOPUS
Safety and anti-tumor effects of vismodegib in patients with refractory advanced gastric cancer: A single-arm phase-II trialopen access

Kim, Ryul; Ji, Jun Ho; Kim, Jung Hoon; Hong, Jung Yong; Lim, Ho-Yeong; Kang, Won Ki; Lee, Jeeyun; Kim, Seung Tae

ArticleIssue Date2022CitationJournal of Cancer, v.13, no.3, pp 1097 - 1102PublisherIvyspring International Publisher
SCISCIESCOPUS
Safety and efficacy of trastuzumab administered as a 30-min infusion in patients with HER2-positive advanced gastric cancer

Oh, Sung Yong; Lee, Suee; Huh, Seok Jae; Lee, Jeeyun; Kim, Seung Tae; Park, Se Hoon; Lim, Ho Yeong; Kang, Won Ki; Kang, Byung Woog; Kim, Jong Gwang, et al.

ArticleIssue Date2019CitationCancer Chemotherapy and Pharmacology, v.83, no.3, pp 501 - 508PublisherSpringer Verlag
SCISCIESCOPUS
Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone

Kang, Jung Hun; Lee, Soon Il; Lim, Do Hyoung; Park, Keon-Woo; Oh, Sung Yong; Kwon, Hyuk-Chan; Hwang, In Gyu; Lee, Sang-Cheol; Nam, Eunmi; Shin, Dong Bok, et al.

ArticleIssue Date2012CitationJOURNAL OF CLINICAL ONCOLOGY, v.30, no.13, pp 1513 - 1518PublisherAMER SOC CLINICAL ONCOLOGY
SCISCIESCOPUS
Simvastatin plus capecitabine-cisplatin versus placebo plus capecitabine-cisplatin in patients with previously untreated advanced gastric cancer: A double-blind randomised phase 3 study

Kim, Seung Tae; Kang, Jung Hun; Lee, Jeeyun; Park, Se Hoon; Park, Joon Oh; Park, Young Suk; Lim, Ho Yeong; Hwang, In Gyu; Lee, Sang-Cheol; Park, Keon-Woo, et al.

ArticleIssue Date2014CitationEUROPEAN JOURNAL OF CANCER, v.50, no.16, pp 2822 - 2830PublisherELSEVIER SCI LTD
SCIESCOPUS
The impact of primary tumor site on outcomes of treatment with etoposide and cisplatin in grade 3 gastroenteropancreatic neuroendocrine carcinomaopen access

Yoon, Sang Eun; Kim, Jung Hoon; Lee, Su Jin; Lee, Jeeyun; Park, Se Hoon; Lim, Ho Yeong; Kang, Won Ki; Park, Young Suk; Kim, Seung Tae; Park, Joon Oh

ArticleIssue Date2019CitationJOURNAL OF CANCER, v.10, no.14, pp 3140 - 3144PublisherIVYSPRING INT PUBL
SCIESCOPUS
Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial

Lee, Jeeyun; Kim, Seung Tae; Kim, Kyung; Lee, Hyuk; Kozarewa, Iwanka; Mortimer, Peter G. S.; Odegaard, Justin I.; Harrington, Elizabeth A.; Lee, Juyoung; Lee, Taehyang, et al.

ArticleIssue Date2019CitationCANCER DISCOVERY, v.9, no.10, pp 1388 - 1405PublisherAMER ASSOC CANCER RESEARCH
1

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532

COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어